文献速递免疫规划传染病防控与疫情报告

信号肽工程增强重组PRRSV载体中CSFV E2的分泌表达

Enhancing secretory expression of CSFV E2 glycoprotein via signal peptide engineering in a recombinant PRRSV vector platform.
PubMed 文献 · Vaccine · 2026-08-05

以PRRSV减毒株vHuN4-F112为骨架构建rPRRSV-E2(含内源信号肽与TRS)和rPRRSV-E2-△SP(缺失信号肽保留TRS)两株重组病毒,研究信号肽对CSFV E2表达、分泌、结构及免疫原性的调控。两株均遗传稳定并表达E2,信号肽驱动52 kDa糖基化E2高效胞外分泌,而缺失株仅产生胞内40 kDa非糖基化E2。猪体试验中两株均耐受良好且10天诱导PRRSV血清转阳,但仅rPRRSV-E2诱导持续CSFV特异性抗体。

要点

  • 信号肽驱动52 kDa糖基化E2高效胞外分泌,缺失株仅产胞内40 kDa非糖基化E2。
  • 两株重组病毒均遗传稳定、斑块形态似亲本并稳定表达E2。
  • 猪体仅rPRRSV-E2诱导持续CSFV特异性抗体,两株均10天PRRSV血清转阳。

核心结论

  • 信号肽工程可增强重组PRRSV载体中CSFV E2的分泌表达与免疫原性,为PRRS与CSF联合预防提供实用策略。

研究设计与样本

  • 以PRRSV减毒株vHuN4-F112为骨架构建rPRRSV-E2(含内源信号肽与TRS)和rPRRSV-E2-△SP(缺失信号肽保留TRS)两株重组病毒。

主要发现

  • 两株重组病毒均保持高遗传稳定性、亲本样斑块形态并稳定表达E2。
  • 信号肽驱动52 kDa糖基化E2高效胞外分泌,rPRRSV-E2-△SP仅产生胞内40 kDa非糖基化E2。
  • 生物信息学分析证实信号肽保留E2全部五个保守N-糖基化位点及整体折叠。
  • 体外试验揭示信号肽对E2分泌、糖基化及胞内转运的调控作用。
  • 猪体中两株候选均耐受良好并于免疫后10天诱导PRRSV血清转阳,但仅rPRRSV-E2诱导持续CSFV特异性抗体。

临床怎么用

  • 在PRRSV载体多价疫苗设计中可考虑保留信号肽以增强外源抗原分泌与免疫原性。
  • 候选疫苗免疫后10天可观察PRRSV血清转阳,CSFV抗体持续应答需关注信号肽保留情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Porcine Reproductive and Respiratory Syndrome (PRRS) and Classical Swine Fever (CSF) are major threats to swine production, emphasizing the need for effective bivalent vaccines. Using the attenuated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) strain vHuN4-F112 as the backbone, we generated two recombinant viruses: rPRRSV-E2 (carrying an endogenous signal peptide and transcription regulatory sequence (TRS) element) and rPRRSV-E2-△SP (signal peptide-deleted but TRS-retained). We investigated how the signal peptide modulates the expression, secretion, structural features, and immunogenicity of Classical Swine Fever Virus (CSFV) E2. Both recombinants maintained high genetic stability, exhibited parental-like plaque morphology, and stably expressed E2. The signal peptide drove efficient extracellular secretion of 52 kDa glycosylated E2, whereas rPRRSV-E2-△SP only produced an intracellular 40 kDa non-glycosylated form. Bioinformatic analysis confirmed that the signal peptide preserved all five conserved N-glycosylation sites and the overall fold of E2. In vitro assays further revealed the regulatory effects of the signal peptide on E2 secretion, glycosylation, and intracellular trafficking. In pigs, both candidates were well tolerated and induced PRRSV seroconversion by 10 days post-immunization, but only rPRRSV-E2 elicited sustained CSFV-specific antibodies. The enhanced immunogenicity likely arises from improved E2 secretion, augmented APC activation, and modulated cytokine profiles, which may counteract PRRSV-induced immunosuppression. Our findings provide a practical strategy for the co-prevention of PRRS and CSF, and offer guidance for multivalent vaccine design.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Guo Z, Zhao L, Li J, et al. Enhancing secretory expression of CSFV E2 glycoprotein via signal peptide engineering in a recombinant PRRSV vector platform. Vaccine. 2026. PMID: 42556298. doi:10.1016/j.vaccine.2026.129005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。